MATUZUMAB
UNII MG4M3QB242

Substance Identification & Data

This profile provides standardized clinical and technical data for Matuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MG4M3QB242.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 339186-68-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MG4M3QB242

CAS Registry Number

339186-68-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MATUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2012

National Cancer Institute reference terminology for clinical and research data.

INN ID

8103

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Matuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MATUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMANIZED MAB 425 .GAMMA.1 CHAIN), DISULFIDE WITH HUMANIZED MAB 425 .KAPPA.-CHAIN, DIMER

MATUZUMAB [INN]

MATUZUMAB [WHO-DD]